Fagan Associates’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
PAMU
Fagan Associates's XYL Position: Q2 2020 in Review
Fagan Associates sold out of Xylem (XYL) in Q2 2020, closing a stake of 14,770 shares — an estimated $962K sold.
Fagan Associates first reported a position in XYL in Q1 2016 and held it in 17 quarters. The position peaked at $1.76M in Q3 2016. 645 funds tracked by Wall St. Rank hold XYL as of Q2 2020.
- Fagan Associates reported no remaining Xylem position as of Q2 2020 after selling out during the quarter.
- Fagan Associates sold 14,770 Xylem shares in Q2 2020, an estimated $962K.
- Fagan Associates first reported a position in Xylem in Q1 2016 and held it in 17 quarters.
- Fagan Associates's Xylem position peaked at $1.76M in Q3 2016.
- 645 funds tracked by Wall St. Rank held Xylem as of Q2 2020.
Based on Fagan Associates's 13F filing for Q2 2020, filed 5 Aug 2020.